Fink U - Search Results

1

Surgical resection for cancer of the cardia.

Siewert JR, Stein HJ, Sendler A, Fink U. Siewert JR, et al. Among authors: fink u. Semin Surg Oncol. 1999 Sep;17(2):125-31. doi: 10.1002/(sici)1098-2388(199909)17:2<125::aid-ssu7>3.0.co;2-9. Semin Surg Oncol. 1999. PMID: 10449684 Review.

2

Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.

Ott K, Weber WA, Fink U, Helmberger H, Becker K, Stein HJ, Müller J, Schwaiger M, Siewert JR. Ott K, et al. Among authors: fink u. World J Surg. 2003 Sep;27(9):1035-9. doi: 10.1007/s00268-003-7058-9. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917760

3

Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.

Ott K, Sendler A, Becker K, Dittler HJ, Helmberger H, Busch R, Kollmannsberger C, Siewert JR, Fink U. Ott K, et al. Among authors: fink u. Gastric Cancer. 2003;6(3):159-67. doi: 10.1007/s10120-003-0245-4. Gastric Cancer. 2003. PMID: 14520529 Clinical Trial.

4

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, Lorenzen S, Schuster T, Wieder H, Herrmann K, Bredenkamp R, Höfler H, Fink U, Peschel C, Schwaiger M, Siewert JR. Lordick F, et al. Among authors: fink u. Lancet Oncol. 2007 Sep;8(9):797-805. doi: 10.1016/S1470-2045(07)70244-9. Lancet Oncol. 2007. PMID: 17693134 Clinical Trial.

5

Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.

Siewert JR, Lordick F, Ott K, Stein HJ, Weber WA, Becker K, Peschel C, Fink U, Schwaiger M. Siewert JR, et al. Among authors: fink u. Ann Surg. 2007 Oct;246(4):624-8; discussion 628-31. doi: 10.1097/SLA.0b013e318155a7d1. Ann Surg. 2007. PMID: 17893499

6

Neoadjuvant chemotherapy for gastric cancer: update.

Fink U, Stein HJ, Schuhmacher C, Wilke HJ. Fink U, et al. World J Surg. 1995 Jul-Aug;19(4):509-16. doi: 10.1007/BF00294711. World J Surg. 1995. PMID: 7676692 Review.

7

Staging gastrointestinal cancer as a precondition for multimodal treatment.

Siewert JR, Sendler A, Dittler HJ, Fink U, Höfler H. Siewert JR, et al. Among authors: fink u. World J Surg. 1995 Mar-Apr;19(2):168-77. doi: 10.1007/BF00308622. World J Surg. 1995. PMID: 7754619 Review.

8

Multimodal treatment for squamous cell esophageal cancer.

Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR. Fink U, et al. World J Surg. 1995 Mar-Apr;19(2):198-204. doi: 10.1007/BF00308626. World J Surg. 1995. PMID: 7754623 Review.

9

Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus.

Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Roder JD, et al. Among authors: fink u. Br J Surg. 1994 Mar;81(3):410-3. doi: 10.1002/bjs.1800810330. Br J Surg. 1994. PMID: 8173915

10

Surgery of squamous cell carcinoma of the esophagus.

Siewert JR, Fink U, Beckurts KT, Roder JD. Siewert JR, et al. Among authors: fink u. Ann Oncol. 1994;5 Suppl 3:1-7. doi: 10.1093/annonc/5.suppl_3.s1. Ann Oncol. 1994. PMID: 8204524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters